ABSTRACT
Great strides in treatment options have occurred over the past 10 years with considerable benefit to patients. Despite these therapies, GBS continues to have significant morbidity and mortality and places enormous burdens on the community. With the better understanding of mechanisms involved in the pathogenesis of GBS, more specific therapies and/or protective mechanisms for the axon will hopefully be developed.
